This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2024
Title: Innovator Soo Bong Cha and His Contributions to Pharmaceutical Chemistry
Introduction: Soo Bong Cha is a notable inventor based in Daejeon, South Korea. His innovative work has led to the development of several patented compounds that hold potential for addressing medical challenges. With a total of four patents to his name, Cha has made significant strides in pharmaceutical chemistry, particularly concerning glutamate receptor modulation.
Latest Patents: Among his latest contributions are the patents for imidazopyrimidine and imidazotriazine derivatives. These compounds are highlighted in his patent disclosures, which detail a compound of Chemical Formula (1) or its pharmaceutically acceptable salts. These innovations serve as positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5), suggesting their utility in preventing or treating disorders associated with glutamate dysfunction and mGluR5.
Career Highlights: Soo Bong Cha is currently employed at SK Biopharmaceuticals Co., Ltd., a leading company in the biopharmaceutical sector. His work at this institution reflects his commitment to advancing research and development in therapeutics. His expertise and creative approaches have been instrumental in bridging the gap between scientific research and practical medical applications.
Collaborations: Throughout his career, Cha has collaborated with other esteemed professionals such as Chun Eung Park and Young Koo Jang. These partnerships have fostered a productive environment for innovation and have contributed to the successful development of various pharmaceutical projects.
Conclusion: The achievements of Soo Bong Cha exemplify the impact of dedicated inventors in the realm of pharmaceuticals. His patented compounds offer promising avenues for medical treatment and underline the importance of continuous research and innovation in enhancing healthcare outcomes. As he progresses in his career, it is anticipated that Cha will continue to make significant contributions to the field of pharmaceutical chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile